204 related articles for article (PubMed ID: 38596160)
1. Analysis of comprehensive biomolecules in critically ill patients via bioinformatics technologies.
Matsumoto H; Ogura H; Oda J
Acute Med Surg; 2024; 11(1):e944. PubMed ID: 38596160
[TBL] [Abstract][Full Text] [Related]
2. Uncovering heterogeneity in sepsis: a comparative analysis of subphenotypes.
van Amstel RBE; Kennedy JN; Scicluna BP; Bos LDJ; Peters-Sengers H; Butler JM; Cano-Gamez E; Knight JC; Vlaar APJ; Cremer OL; Angus DC; van der Poll T; Seymour CW; van Vught LA;
Intensive Care Med; 2023 Nov; 49(11):1360-1369. PubMed ID: 37851064
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Outcomes in Older Patients with Sepsis in the ICU: A Retrospective Study.
Xu C; Lv L; Hu W; Yu Z; Qian H; Chen F
Altern Ther Health Med; 2024 Feb; 30(2):124-130. PubMed ID: 37856802
[TBL] [Abstract][Full Text] [Related]
4. Multi-Omics Techniques Make it Possible to Analyze Sepsis-Associated Acute Kidney Injury Comprehensively.
Qiao J; Cui L
Front Immunol; 2022; 13():905601. PubMed ID: 35874763
[TBL] [Abstract][Full Text] [Related]
5. Personalizing Care for Critically Ill Adults Using Omics: A Concise Review of Potential Clinical Applications.
See KC
Cells; 2023 Feb; 12(4):. PubMed ID: 36831207
[TBL] [Abstract][Full Text] [Related]
6. "
Gemmati D; Varani K; Bramanti B; Piva R; Bonaccorsi G; Trentini A; Manfrinato MC; Tisato V; Carè A; Bellini T
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906252
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Insights and limits of translational research in critical care medicine.
Pène F; Ait-Oufella H; Taccone FS; Monneret G; Sharshar T; Tamion F; Mira JP;
Ann Intensive Care; 2015; 5():8. PubMed ID: 25977834
[TBL] [Abstract][Full Text] [Related]
9. Towards Personalized Treatment Strategies for Esophageal Adenocarcinoma; A Review on the Molecular Characterization of Esophageal Adenocarcinoma and Current Research Efforts on Individualized Curative Treatment Regimens.
Hoefnagel SJM; Boonstra JJ; Russchen MJAM; Krishnadath KK
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638363
[TBL] [Abstract][Full Text] [Related]
10. Translational validation of personalized treatment strategy based on genetic characteristics of glioblastoma.
Oh YT; Cho HJ; Kim J; Lee JH; Rho K; Seo YJ; Choi YS; Jung HJ; Song HS; Kong DS; Seol HJ; Lee JI; Yoon Y; Kim S; Nam DH; Joo KM
PLoS One; 2014; 9(8):e103327. PubMed ID: 25084005
[TBL] [Abstract][Full Text] [Related]
11. A Detailed Catalogue of Multi-Omics Methodologies for Identification of Putative Biomarkers and Causal Molecular Networks in Translational Cancer Research.
Vlachavas EI; Bohn J; Ückert F; Nürnberg S
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802234
[TBL] [Abstract][Full Text] [Related]
12. Integrative multi-omics and systems bioinformatics in translational neuroscience: A data mining perspective.
O'Connor LM; O'Connor BA; Lim SB; Zeng J; Lo CH
J Pharm Anal; 2023 Aug; 13(8):836-850. PubMed ID: 37719197
[TBL] [Abstract][Full Text] [Related]
13. Feeding the critically ill obese patient: a systematic review protocol.
Secombe P; Harley S; Chapman M; Aromataris E
JBI Database System Rev Implement Rep; 2015 Oct; 13(10):95-109. PubMed ID: 26571286
[TBL] [Abstract][Full Text] [Related]
14. Sepsis in the era of data-driven medicine: personalizing risks, diagnoses, treatments and prognoses.
Liu AC; Patel K; Vunikili RD; Johnson KW; Abdu F; Belman SK; Glicksberg BS; Tandale P; Fontanez R; Mathew OK; Kasarskis A; Mukherjee P; Subramanian L; Dudley JT; Shameer K
Brief Bioinform; 2020 Jul; 21(4):1182-1195. PubMed ID: 31190075
[TBL] [Abstract][Full Text] [Related]
15. Nutrient pattern analysis in critically ill patients using Omics technology (NAChO) - Study protocol for a prospective observational study.
Schefold JC; Messmer AS; Wenger S; Müller L; von Haehling S; Doehner W; McPhee JS; Fux M; Rösler KM; Scheidegger O; Olariu R; Z'Graggen W; Rezzi S; Grathwohl D; Konz T; Takala J; Cuenoud B; Jakob SM
Medicine (Baltimore); 2019 Jan; 98(1):e13937. PubMed ID: 30608424
[TBL] [Abstract][Full Text] [Related]
16. [The prognostic value of serum procalcitonin on severity of illness in non-sepsis critically ill patients].
Ma J; Wang S; Chen D; Duan J; Li C; Li G
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Aug; 28(8):688-93. PubMed ID: 27434557
[TBL] [Abstract][Full Text] [Related]
17. From molecular mechanisms of prostate cancer to translational applications: based on multi-omics fusion analysis and intelligent medicine.
Ren S; Li J; Dorado J; Sierra A; González-Díaz H; Duardo A; Shen B
Health Inf Sci Syst; 2024 Dec; 12(1):6. PubMed ID: 38125666
[TBL] [Abstract][Full Text] [Related]
18. Plasma interleukin-6 concentration for the diagnosis of sepsis in critically ill adults.
Molano Franco D; Arevalo-Rodriguez I; Roqué I Figuls M; Montero Oleas NG; Nuvials X; Zamora J
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD011811. PubMed ID: 31038735
[TBL] [Abstract][Full Text] [Related]
19. Recent progress in biomolecular engineering.
Ryu DD; Nam DH
Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
[TBL] [Abstract][Full Text] [Related]
20. Tangled quest of post-COVID-19 infection-caused neuropathology and what 3P nano-bio-medicine can solve?
Hamdy NM; Shaker FH; Zhan X; Basalious EB
EPMA J; 2022 Jun; 13(2):261-284. PubMed ID: 35668839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
